Implant Sciences to Conduct Press Conference & Demonstration of its QS-B220 Explosives Trace Detector on Monday, November 17 at 10:30am ET

WILMINGTON, Mass., Nov. 14, 2014 /PRNewswire/ -- Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will conduct a press conference on Monday, November 17, 2014 at 10:30 am ET at the Marriott Marquis Times Square, New York City. Implant Sciences will discuss significant recent Company events and will conduct live demonstrations of the QS-B220, which is the first non-radioactive explosives trace detector (ETD) to be approved for baggage and passenger screening by the TSA.

A live webcast of the press conference will be available at the following link: http://www.wsw.com/webcast/cc/imsc/

Members of media interested in attending the event may contact: Janet Vasquez at 212-645-5498 or [email protected].

About Implant Sciences

Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. Implant Sciences is only the third manufacturer, and the sole American-owned company, to currently have an ETD system named as a Qualified Product by the US Transportation Security Administration. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, STAC in France, the German Ministry of the Interior, and the Ministry of Public Safety in China. It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution".  All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.

Contact:

Implant Sciences Corporation
Company Contact:
Glenn Bolduc, CEO
978-752-1700       

or

Investor Contact:
Laurel Moody
646-810-0608  

SOURCE Implant Sciences Corporation

Related Links

http://www.implantsciences.com